高速铁路无砟轨道静态精调技术分析及应用

来源 :上海铁道科技 | 被引量 : 0次 | 上传用户:kary_yeah
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
高速铁路无砟轨道静态精调影响到运营后的轨道质量和后续的维护保养,是高速铁路运营前的关键工作,目前的轨道静态精调作业需要耗费大量的人工材料。通过对传统的无砟轨道精调作业及效果和改进的无砟轨道精调作业及效果进行对比,并针对具体的工程实例进行分析,证明改进的轨道精调作业方法可以在不降低精调质量的前提下明显提高轨道精调的作业效率,为今后的高铁无砟轨道精调提供一种新的作业方法。 The static fine tuning of high-speed railway ballastless track affects the track quality and subsequent maintenance after operation. It is a key task before high-speed railway operation. The current orbit static fine-tuning operation requires a lot of man-made materials. By comparing the operation and effect of the traditional ballastless track fine tuning operation and the improved ballastless track fine adjustment and analyzing the specific engineering examples, it is proved that the improved orbital fine tuning operation method can not reduce the fine adjustment quality Under the premise of significantly improve the orbital fine tuning of the operating efficiency for the future high-speed rail ballastless rail fine tuning to provide a new method of operation.
其他文献
为满足重载运输需要和大幅提高货运运输效益,我国铁路在既有线上开行的通用货车轴重不断加大,货车轴重提高以后,已经超出既有驼峰设备设计规范及标准,给减速器的维修带来了很
Background It is important to study the factors affecting the clinical mortality of the severe multiple trauma population. The present study was aimed to identi
目的了解本地乙型肝炎流行状况,探索乙肝流行因素及流行规律。方法随机与整群抽样相结合,对1岁以上共650人进行了乙型肝炎血清流行病学调查。结果HBsAg阳性率为2.15%,低于200
Background Central venous thrombosis is a serious and life-threatening complication in hemodialysis (HD) patients with an indwelling catheter. The present study
目的探讨高海拔地区大鼠30%Ⅲ度烧伤后肝细胞损伤程度以及复方红景天对其保护作用机制。方法104只Wistar大鼠随机分为实验组、对照组1组各48只,另取8只作为对照2组;实验组大
Background Detection of coronary microembolization is of clinical importance for patient management and prediction of long-term outcome. However, there are few
目的调查神经外科住院患者医院感染发生情况,找出医院感染发生的相关因素,提出控制医院感染的有效措施。方法医院感染专职监控人员每日到病房了解患者发生感染的情况,发生感
Coronary stents have been used as standard mechanical devices for percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD).1-3 T